Norway Life Science 2024 gathers leading actors in health and life science, to find the solutions that will allow Norway to get more in return from the large investments in health research.
University of Oslo, together with Oslo Science City, Oslo University Hospital, NMBU – Norwegian University of Life Sciences, SINTEF, Association of the Pharmaceutical Industry in Norway, Oslo Cancer Cluster and The Life Science Cluster, welcome you to Norway's largest and most important conference for health and life science: Norway Life Science 2024.
Save the date, February 13 – 14, the registration opens in early December.
The main theme of the conference is health data, and the aim is to help increase Norway's competitiveness in access to and use of such data. Compared to our European neighbouring countries, Norway gets less return from the large investments in health research in the form of patents, new companies, and export revenues from the health industry. Better access to health data for research and innovation, within clear ethical and privacy boundaries, will help strengthen Norwegian research environments, develop better treatments for patients, and create new jobs and export revenues.
– National, quality-based competition arenas have contributed to UiO having some of the country's foremost research environments in this field. To succeed with the ambition of developing a knowledge-based business community, cooperation within and across sectors is crucial. This conference facilitates that, says Svein Stølen, rector at UiO.
Gathers the entire value chain
At the conference, we gather the entire value chain for health and life science. Andrew Morris, Director of Health Data Research UK, shares experiences from the UK, and key actors from Finland, Denmark and Sweden will talk about measures and initiatives to make health data available for developing new knowledge and treatments. You also get to hear from the country's leading research environments, the central leaders in the health sector, world-leading pharmaceutical companies, startup environments, investors, and decision-makers.
The conference is an Oslo Science City Arena event, with leading representatives of the health industry as industry partners.
– To develop a strong Norwegian health industry and rig the Norwegian health service for the future, we need to strengthen the cooperation between researchers, industry, public actors, and investors. Norway's first innovation district, Oslo Science City, is a platform for building this cooperation. And there is no better place to meet than here, in this innovation district where two thirds of health research in Norway is conducted, says Christine Wergeland Sørbye, Managing Director at Oslo Science City.
Programme and registration are coming in early December.
Leave your name and email, and we will keep you updated about the Norway Life Science 2024.